Meribank Biotech Co., Ltd (TPEX:4724)

Meribank Biotech Revenue

Meribank Biotech had revenue of 250.42M TWD in the half year ending June 30, 2025, with 142.98% growth. This brings the company's revenue in the last twelve months to 486.52M, up 85.97% year-over-year. In the year 2024, Meribank Biotech had annual revenue of 366.43M with 56.37% growth.

• Revenue (ttm): 486.52M
• Revenue Growth: +85.97%
• P/S Ratio: 2.78
• Revenue / Employee: 3.43M
• Employees: 142
• Market Cap: 1.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	366.43M	132.09M	56.37%
Dec 31, 2023	234.34M	54.22M	30.10%
Dec 31, 2022	180.12M	17.04M	10.45%
Dec 31, 2021	163.08M	-31.32M	-16.11%
Dec 31, 2020	194.39M	33.44M	20.78%